https://www.selleckchem.com/pr....oducts/tulmimetostat
th patient outcome. These findings provide valuable insights on the PDAC microenvironment and could potentially inform the management of PDAC patients. Taken together, our work identifies significant heterogeneity in cellular compositions of PDAC tumors and between primary tumors and metastatic lesions. Furthermore, the cellular composition was an important factor in defining PDAC subtypes and significantly correlated with patient outcome. These findings provide valuable insights on the PDAC microenvironment and could potentially
Мне нравится
Комментарий
Перепост
